| Vesatolimod, a toll-like receptor 7 agonist, induces immune activation in virally suppressed adults living with human immunodeficiency virus–1 SA Riddler, M Para, CA Benson, A Mills, M Ramgopal, E DeJesus, ... Clinical Infectious Diseases 72 (11), e815-e824, 2021 | 61 | 2021 |
| Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers H Patel, A Andresen, A Vente, HD Heilmann, W Stubbings, M Seiberling, ... Antimicrobial agents and chemotherapy 55 (9), 4386-4393, 2011 | 28 | 2011 |
| Efficacy and safety of long-acting subcutaneous lenacapavir in phase 2/3 in heavily treatment-experienced people with HIV: week 26 results (Capella study) JM Molina, S Segal-Maurer, HJ Stellbrink, A Castagna, M Berhe, ... International AIDS Society(IAS) Conference on HIV Sciences, 2021 | 26 | 2021 |
| Urinary Pharmacokinetics and Bactericidal Activity of Finafloxacin (FIN) (800mg) in Healthy Volunteers Receiving a Single Oral Dose FME Wagenlehner, C Wagenlehner, H Blenk, B, Blenk, W Stubbings, ... 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)-Infect. Dis …, 2008 | 23 | 2008 |
| Dose-response Relationship of Subcutaneous Long-Acting HIV Capsid Inhibitor GS-6207 E Daar, C McDonal, G Crofoot, P Ruane, G Sinclair, E DeJesus, M Berhe, ... Topics in Antiviral Medicine (IAS-USA) 28 (1), 165, 2020 | 17 | 2020 |
| Dose-response Relationship of Subcutaneous Long-Acting HIV Capsid Inhibitor GS-6207 E Daar, C McDonal, G Crofoot, P Ruane, G Sinclair, E DeJesus, M Berhe, ... Conference on Retroviruses and Opportunistic Infections, 2020 | 17 | 2020 |
| Safety and antiviral activity over 10 days following a single dose of subcutaneous GS-6207, a first-in-class, long-acting HIV capsid inhibitor in people living with HIV E Daar, C McDonald, G Crofoot, P Ruane, G Sinclair, H Patel, J Sager, ... IAS (International AIDS Society) Conference on HIV Science, Mexico, 2019 | 10 | 2019 |
| Vesatolimod (GS‑9620) is safe and pharmacodynamically active in HIV infected individuals S Riddler, M Para, C Benson, A Mills, M Ramgopal, E DeJesus, C Brinson, ... 10th International AIDS Society Conference on HIV Science (IAS 2019), Mexico …, 2019 | 8 | 2019 |
| Vesatolimod (GS-9620) is safe and pharmacodynamically active in HIV-infected individuals S Riddler, M Para, C Benson, A Mills, M Ramgopal, E DeJesus, C Brinson, ... Journal of Virus Eradication 5 (Supplement 2, July 2019), 3,, 2019 | 8 | 2019 |
| Rapid Activity of Finafloxacin in Patients with Urinary Tract Infections and Pyelonephritis Evaluated in Phase 2 Clinical Studies A Vente, H Patel, PA Tambyah, D Fischer, W Stubbings, M Lückermann, ... Antimicrobial Agents and Chemotherapy, 2015 171 (L-1250), 171, 2015 | 4 | 2015 |
| Safety and analytic treatment interruption outcomes of vesatolimod in HIV controllers D SenGupta, M Ramgopal, C Brinson, E DeJesus, A Mills, P Shalit, ... Conference on Retroviruses and Opportunistic Infections, 8-11, 2020 | 3 | 2020 |
| Single doses of long-acting capsid inhibitor GS-6207 administered by subcutaneous injection are safe and efficacious in people living with HIV ES Daar, C McDonald, G Crofoot, P Ruane, G Sinclair, H Patel, R Begley, ... European AIDS Conference, Basel, 2019 | 3 | 2019 |
| A phase I study to determine safety, tolerability and pharmacokinetics (PK) of intravenous doses of finafloxacin HCI (FIN) in healthy subjects [abstract no. A-1960] M Luckermann, L Mooney, H Patel 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy 12, 2012 | 3 | 2012 |
| A phase I study to determine safety, tolerability and pharmacokinetics (PK) of finafloxacin (FIN) in healthy subjects, poster F1-2048 H Patel Abstr. 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother.(ICAAC …, 2008 | 2* | 2008 |
| Single doses of long-acting capsid inhibitor GS-6207 administered by subcutaneous injection are well tolerated and efficacious in people living with HIV ES Daar, C McDonald, G Crofoot, P Ruane, G Sinclair, H Patel, J Sager, ... HIV MEDICINE 21, 13-14, 2020 | | 2020 |
| Safety and Analytical Treatment Outcomes of Vesatolimod in HIV Controllers D SenGupta, M Ramgopal, C Brinson, E DeJesus, A Mills, P Shalit, ... Topics in Antiviral Medicine (IAS-USA) 28 (1), 13-14, 2020 | | 2020 |
